Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Can multiple sclerosis as a cognitive disorder influence patients' dreams?
Everyday memory impairment, neuroradiological findings and physical disability in multiple sclerosis.
Efficacy and safety of fingolimod (FTY720) in patients with relapsing-remitting multiple sclerosis (FREEDOMS II)
Sleep disturbances in patients with multiple sclerosis.
Understanding hope in patients with Multiple Sclerosis.
[Good practice in prophylactic care: prophylactic care and professional activation of employees with multiple sclerosis].
The cooling effect on proinflammatory cytokines interferon-gamma, tumor necrosis factor-alpha, and nitric oxide in patients with multiple sclerosis.
Oligodendrocyte Regeneration and CNS Remyelination Require TACE/ADAM17.
[Vitamin D in Multiple Sclerosis].
Resolvin D1 and E1 promote resolution of inflammation in microglial cells in vitro.
Indirect costs of absenteeism due to rheumatoid arthritis, psoriasis, multiple sclerosis, insulin-dependent diabetes mellitus, and ulcerative colitis in 2012: a study based on real-life data from the Social Insurance Institution in Poland.
HDAC1/2-Dependent P0 Expression Maintains Paranodal and Nodal Integrity Independently of Myelin Stability through Interactions with Neurofascins.
Correction: The Association of Vitamin D Receptor Polymorphisms with Multiple Sclerosis in a Case-Control Study from Kuwait.
Predicting Breakdown of the Blood-Brain Barrier in Multiple Sclerosis without Contrast Agents.
A review of induced pluripotent stem cell, direct conversion by trans-differentiation, direct reprogramming and oligodendrocyte differentiation.
Brain atrophy as a non-response predictor to interferon-beta in relapsing-remitting multiple sclerosis.
Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases.
Teriflunomide (Aubagio®) for the treatment of multiple sclerosis.
Iron and multiple sclerosis.
Environmental Pathology: SY09-2 MULTIPLE SCLEROSIS (MS) AND NEURODEGENERATION: CAUSE AND PATHOGENESIS IN RELATION TO ELECTROMAGNETIC FIELDS (EMF).
Age-related Shift in Neural Complexity Related to Task Performance and Physical Activity.
Is high socioeconomic status a risk factor for multiple sclerosis? A systematic review.
Interferon Beta and vitamin d synergize to induce immunoregulatory receptors on peripheral blood monocytes of multiple sclerosis patients.
Nuclear export inhibitors avert progression in preclinical models of inflammatory demyelination.
Deletion of Mitochondrial Anchoring Protects Dysmyelinating Shiverer: Implications for Progressive MS.
Pages
« first
‹ previous
…
462
463
464
465
466
467
468
469
470
…
next ›
last »